Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 5;13(2):9278.
doi: 10.4081/dr.2021.9278. eCollection 2021 Aug 1.

Integrated care pathways and the hub-and-spoke model for the management of non-melanoma skin cancer: A proposal of the Italian Association of Hospital Dermatologists (ADOI)

Affiliations

Integrated care pathways and the hub-and-spoke model for the management of non-melanoma skin cancer: A proposal of the Italian Association of Hospital Dermatologists (ADOI)

Luca Fania et al. Dermatol Reports. .

Abstract

The term non-melanoma skin cancer (NMSC) refers to skin cancer different from melanoma, and it is usually restricted to basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and their pre-cancerous lesions, e.g., actinic keratosis. These conditions represent the most frequent tumors in Caucasians and are characterized by an increasing incidence worldwide and a high socio-economic impact. The term Integrated Care Pathway (ICP) refers to "a complex intervention for the mutual decision making and organization of care processes for a well-defined group of patients during a well-defined period". The purpose of this paper is to present a proposal from the Italian Association of Hospital Dermatologists (ADOI) for an ICP organization of care of NMSC, considering the hub-and-spoke model in the different geographical areas. This proposal is based on the most recent literature and on documents from the Italian Association of Medical Oncology (AIOM), the European consensus-based interdisciplinary guidelines from the European Association of Dermato- Oncology (EADO), and the National Comprehensive Cancer Network (NCCN). We initially discuss the NMSC outpatient clinic, the role of the multidisciplinary working groups, and the hub-and-spoke model regarding this topic. Then, we define the ICP processes specific for BCC and SCC. The ICP for NMSC is an innovative strategy to guarantee the highest possible quality of health care while the hub-andspoke model is crucial for the organization of different health care structures. Considering the importance on this topic, it is essential to create a valid ICP together with an efficient organization within the different geographical areas.

Keywords: Actinic keratosis; Basal cell carcinoma; Integrated care pathway; Nonmelanoma skin cancer; Squamous cell carcinoma; hub and spoke model.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None.

Figures

Figure 1.
Figure 1.
The hub-and-spoke model. The hub-and-spoke organization design is a model characterized by service delivery assets into a network involving an anchor establishment (hub) offering a full array of services, complemented by secondary establishments (spokes) offering more limited service arrays, routing patients needing more intensive services to the hub for treatment.
Figure 2.
Figure 2.
The integrated care pathway for non-melanoma skin cancers between different institutional centres. Local dermatology outpatient clinic should treat patients affected by low risk BCC or SCC, while, general hospital with a Dermatology Unit could manage intermediate and high-risk BCC or high and very high risk SCC. More complicated cases (i.e., locally advanced or metastatic BCC or SCC, high risk BCC, or very high-risk SCC) should be managed by tertiary node with skin cancer centres and oncologic services organised in multidisciplinary working group (MWG). GP: general practitioner; PDT: photodynamic therapy; MWG: Multidisciplinary working group; RT: radiotherapy; ECT: electrochemotherapy.
Figure 3.
Figure 3.
Multidisciplinary working group. The multidisciplinary working group (MWG), integrating their specific skills, include professional figures such as dermatologist, medical oncologist, general surgeon, plastic surgeon, radiation oncologist, radiologist, anatomopathologist, and epidemiologist.
Figure 4.
Figure 4.
Main therapeutic indications for locally advanced and metastatic cutaneous SCC as indicated in the “European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2” in 2020. SCC, cutaneous squamous cell carcinoma; RT, radiotherapy; EGFRi, epidermal growth factor receptor inhibitors.

References

    1. Guy GP, Ekwueme DU. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: A systematic review of the literature. Pharmacoeconomics 2011;29:863-74. - PubMed
    1. Wang GY, Wang J, Mancianti M-L, Epstein EH. Basal Cell Carcinomas Arise from Hair Follicle Stem Cells in Ptch1+/− Mice. Cancer Cell 2011;19:114-24. - PMC - PubMed
    1. Fania L, Didona D, Morese R, et al. Basal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines 2020;8(11). - PMC - PubMed
    1. Boi S, Cristofolini M, Micciolo R, et al. Epidemiology of Skin Tumors: Data from the Cutaneous Cancer Registry in Trentino, Italy. J Cutan Med Surg Inc Med Surg Dermatology 2003;7:300-5. - PubMed
    1. Fania L, Didona D, Di Pietro FRFR, et al. Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines 2021;9(2). - PMC - PubMed